Melissa Sayers is the Manager of the Drug Team at Registrar Corp, where she leads teams supporting global pharmaceutical companies in navigating complex regulatory requirements across the United States and international markets. With over a decade of experience in pharmaceutical regulatory compliance, Melissa specializes in electronic submissions, including Structured Product Labeling (SPL) and electronic Common Technical Document (eCTD) formats. She has extensive experience supporting submissions to the U.S. Food and Drug Administration (FDA), Health Canada, and European regulatory agencies, helping organizations maintain compliance across multiple jurisdictions. Melissa’s expertise spans a wide range of regulatory programs and requirements, including drug establishment registration and listing, Generic Drug User Fee Amendments (GDUFA) and Over-the-Counter Monograph User Fee Program (OMUFA), CARES Act reporting, and compliance support for biologics, outsourcing facilities (503B), compounders, third-party logistics providers (3PLs), and wholesale distributors (WDD). Throughout her career, she has guided pharmaceutical companies through complex filings, product reporting obligations, and user fee requirements, with a focus on ensuring accuracy, efficiency, and regulatory alignment. She is also a recognized speaker and educator, regularly delivering industry webinars and training on evolving FDA regulations and compliance strategies. Melissa holds a Master of Science degree from Old Dominion University and has been with Registrar Corp since 2012, where she continues to support innovation and process improvement in regulatory submissions and client services.